Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Desjarlais

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Trends in Biotechnology|September 27, 2003
Negative design for improved therapeutic proteinsJohn R Desjarlais, Greg A Lazar
Annual Review of Medicine|November 1, 2018
Redirected T Cell Cytotoxicity in Cancer TherapyRaphael A Clynes, John R Desjarlais
Experimental Cell Research|April 5, 2011
Modulation of antibody effector functionJohn R Desjarlais, Greg A Lazar
Proteins|April 16, 2003
Increased detection of structural templates using alignments of designed sequencesStefan M Larson, Amit Garg, John R Desjarlais, et al.
Protein Science : a Publication of the Protein Society|September 23, 2003
A de novo redesign of the WW domainChristina M Kraemer-Pecore, Juliette T J Lecomte, John R Desjarlais
Drug Discovery Today|March 14, 2003
Rational design and engineering of therapeutic proteinsShannon A Marshall, Greg A Lazar, Arthur J Chirino, et al.
Drug Discovery Today|November 13, 2007
Optimizing engagement of the immune system by anti-tumor antibodies: an engineer's perspectiveJohn R Desjarlais, Greg A Lazar, Eugene A Zhukovsky, et al.
Protein Science : a Publication of the Protein Society|November 21, 2002
Thoroughly sampling sequence space: large-scale protein design of structural ensemblesStefan M Larson, Jeremy L England, John R Desjarlais, et al.
Molecular Immunology|November 3, 2006
A molecular immunology approach to antibody humanization and functional optimizationGreg A Lazar, John R Desjarlais, Jonathan Jacinto, et al.
Current Opinion in Structural Biology|September 2, 2003
Designing proteins for therapeutic applicationsGreg A Lazar, Shannon A Marshall, Joseph J Plecs, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Trends in Biotechnology|September 27, 2003
Negative design for improved therapeutic proteinsJohn R Desjarlais, Greg A Lazar
Annual Review of Medicine|November 1, 2018
Redirected T Cell Cytotoxicity in Cancer TherapyRaphael A Clynes, John R Desjarlais
Experimental Cell Research|April 5, 2011
Modulation of antibody effector functionJohn R Desjarlais, Greg A Lazar
Proteins|April 16, 2003
Increased detection of structural templates using alignments of designed sequencesStefan M Larson, Amit Garg, John R Desjarlais, et al.
Protein Science : a Publication of the Protein Society|September 23, 2003
A de novo redesign of the WW domainChristina M Kraemer-Pecore, Juliette T J Lecomte, John R Desjarlais
Drug Discovery Today|March 14, 2003
Rational design and engineering of therapeutic proteinsShannon A Marshall, Greg A Lazar, Arthur J Chirino, et al.
Drug Discovery Today|November 13, 2007
Optimizing engagement of the immune system by anti-tumor antibodies: an engineer's perspectiveJohn R Desjarlais, Greg A Lazar, Eugene A Zhukovsky, et al.
Protein Science : a Publication of the Protein Society|November 21, 2002
Thoroughly sampling sequence space: large-scale protein design of structural ensemblesStefan M Larson, Jeremy L England, John R Desjarlais, et al.
Molecular Immunology|November 3, 2006
A molecular immunology approach to antibody humanization and functional optimizationGreg A Lazar, John R Desjarlais, Jonathan Jacinto, et al.
Current Opinion in Structural Biology|September 2, 2003
Designing proteins for therapeutic applicationsGreg A Lazar, Shannon A Marshall, Joseph J Plecs, et al.
Pageof 4